Follicular lymphoma in early stages: High risk of relapse and usefulness of the Follicular Lymphoma International Prognostic Index to predict the outcome of patients

European Journal of Haematology

Volumn 76, Issue 1, 2006, Pages 58-63

  Plancarte, Francisco ^a   López Guillermo, Armando ^a   Arenillas, Leonor ^a   Montoto, Silvia ^a   Giné, Eva ^a   Muntañola, Ana ^a   Ferrer, Ana ^a   Villamor, Neus ^a   Bosch, Francesc ^a   Colomo, Lluis ^a   Balaguer, Olga ^a   Campo, Elías ^a   Montserrat, Emili ^a  

^a HOSPITAL CLÍNIC   (Spain)

Author keywords

Early stage; Follicular lymphoma; Follicular Lymphoma International Prognostic Index; Prognosis

Indexed keywords

CYCLOPHOSPHAMIDE; DOXORUBICIN; PREDNISONE; VINCRISTINE; ANTINEOPLASTIC AGENT; CHOP PROTOCOL;

ADULT; AGED; ARTICLE; CANCER CLASSIFICATION; CANCER MORTALITY; CANCER PATIENT; CANCER RADIOTHERAPY; CANCER RISK; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; DISEASE CLASSIFICATION; DISEASE FREE SURVIVAL; DRUG TREATMENT FAILURE; EARLY CANCER; FEMALE; FOLLICULAR LYMPHOMA; FOLLOW UP; HIGH RISK PATIENT; HUMAN; LEUKEMIA RELAPSE; MALE; MALIGNANT TRANSFORMATION; MEDICAL ASSESSMENT; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; TREATMENT RESPONSE; AGE; CANCER STAGING; MIDDLE AGED; MORTALITY; MULTIMODALITY CANCER THERAPY; PATHOLOGY; PREDICTION AND FORECASTING; RADIOTHERAPY; RECURRENT DISEASE; RISK FACTOR; SURVIVAL RATE;

ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; COMBINED MODALITY THERAPY; CYCLOPHOSPHAMIDE; DISEASE-FREE SURVIVAL; DOXORUBICIN; FEMALE; FOLLOW-UP STUDIES; HUMANS; LYMPHOMA, FOLLICULAR; MALE; MIDDLE AGED; NEOPLASM STAGING; PREDICTIVE VALUE OF TESTS; PREDNISONE; PROGNOSIS; RADIOTHERAPY; RECURRENCE; RISK FACTORS; SURVIVAL RATE; VINCRISTINE;

EID: 33644876017     PISSN: 09024441     EISSN: 16000609     Source Type: Journal    
DOI: 10.1111/j.1600-0609.2005.00564.x     Document Type: Article

References (28)

1. The Non-Hodgkin's Lymphoma Classification Project A clinical evaluation of the international lymphoma study group classification of non-Hodgkin's lymphoma Blood 1997 89 3909 3918
2. N athwani BN H arris NL W eisenburger D et al. Follicular lymphoma In J affe ES H arris N S tein H V ardiman JW eds World Health Organization Classification of Tumours. Pathology and Genetics. Tumours of Haematopoietic and Lymphoid Tissues Lyon, France IARC Press 2001 162 167
3. W inter JN G ascoyne RD V an B esien K Low grade lymphoma Hematology (Am Soc Hematol Educ Program) 2004 203 220
4. L ister TA The management of follicular lymphoma Ann Oncol 1991 2 131 137
5. S olal -C éligny P R oy P C olombat P et al. Follicular Lymphoma International Prognostic Index Blood 2004 104 1258 1264
6. L ópez -G uillermo A M ontserrat E B osch F et al. Low-grade lymphoma: clinical and prognostic studies in a series of 143 patients from a single institution Leuk Lymphoma 1994 15 159 165
7. L ópez -G uillermo A M ontserrat E B osch F et al. Applicability of the International Index for aggressive lymphomas to patients with low-grade lymphoma J Clin Oncol 1994 12 1343 1348
8. M ontoto S L ópez -G uillermo A A ltes A et al. Predictive value of Follicular Lymphoma International Prognostic Index (FLIPI) in patients with follicular lymphoma at first progression Ann Oncol 2004 15 1489 1490
9. N issen N E rsboll J S and H et al. A randomized study of radiotherapy vs. radiotherapy plus chemotherapy in stage I-II non-Hodgkin's lymphomas Cancer 1983 52 1 7
10. M c L aughlin P F uller LM V elasquez WS et al. Stage I-II follicular lymphoma. Treatment results for 76 patients Cancer 1986 58 1596 1602
11. M c L aughlin P F uller L R edman J et al. Stage I-II low-grade lymphoma: a prospective trial of combination chemotherapy and radiotherapy Ann Oncol 1991 2 Suppl. 2 137 140
12. T sutsui K S hibamoto Y Y amabe H et al. A radiotherapeutic experience for localized extranodal non-Hodgkin's lymphoma: prognostic factors and re-evaluation of treatment modality Radiother Oncol 1991 21 83 90
13. M ac M anus MP H oppe RT Is radiotherapy curative for stage I and II low-grade follicular lymphoma? Results of a long-term follow-up study of patients treated at Stanford University J Clin Oncol 1996 14 1282 1290
14. M ac M anus MP R ainer B owie CA H oppe RT What is the prognosis for patients who relapse after primary radiation therapy for early-stage low-grade follicular lymphoma Int J Radiat Oncol Biol Phys 1998 42 365 371
15. W ilder RB J ones D T ucker SL et al. Long-term results with radiotherapy for stage I-II follicular lymphomas Int J Radiat Oncol Biol Phys 2001 51 1219 1227
16. S eymour JF P ro B F uller LM et al. Long-term follow-up of a prospective study of combined modality therapy for stage I-II indolent non-Hodgkin's lymphoma J Clin Oncol 2003 21 2115 2122
17. A dvani R R osenberg SA H orning SJ Stage I and II follicular non-Hodgkin's lymphoma: long-term follow-up of no initial therapy J Clin Oncol 2004 22 1454 1459
18. P eterson PM G ospodarowitz M T sang R et al. Long-term outcome in stage I and II follicular lymphoma following treatment with involved field radiation therapy alone Proc ASCO 2004 23 561
19. C heson BD H orning SJ C oiffier B et al. Report of an international workshop to standardize response criteria for non-Hodgkin's lymphomas. NCI Sponsored International Working Group J Clin Oncol 1999 17 1244 1253
20. The International Non-Hodgkin's Lymphoma Prognostic Factors Project A predictive model for aggressive non-Hodgkin's lymphoma N Engl J Med 1993 329 987 994
21. K aplan GL M eier P Non-parametric estimation from incomplete observations J Am Stat Assoc 1958 53 457 481
22. 2/E in the log-rank test for survival data or tumour incidence data Biometrics 1973 29 759 784
23. C ox DR Regression model and life tables J Am Stat Assoc 1972 34 187 220
24. A rmitage EB S meland S K valoy H et al. Prediction of survival in follicular lymphoma based on molecular features of tumor-infiltrating immune cells N Engl J Med 2004 351 2159 2169
25. L ópez -G uillermo A C abanillas F M c L aughlin P et al. The clinical significance of molecular response in indolent follicular lymphomas Blood 1998 91 2955 2960
26. L ópez -G uillermo A C abanillas F M c L aughlin P et al. Molecular response assessed by PCR is the most important factor predicting failure-free survival in indolent follicular lymphoma: update of the MDACC series Ann Oncol 2000 11 137 140
27. H a CS C abanillas F L ee MS et al. Serial determination of the bcl-2 gene in the bone marrow and peripheral blood after central lymphatic irradiation for stages I-III follicular lymphoma: a preliminary report Clin Cancer Res 1997 3 215 219
28. R eyes F L epage E G anem G et al. ACBVP versus CHOP plus radiotherapy for localized aggressive lymphoma N Engl J Med 2005 352 1197 1205